Recombinant HGF (Ficlatuzumab Biosimilar) antibody (PE)

Catalog No. ABIN7867305

The Humanized Monoclonal anti-HGF (Ficlatuzumab Biosimilar) antibody is suitable to detect HGF (Ficlatuzumab Biosimilar) in samples from Human.

Quick Overview for Recombinant HGF (Ficlatuzumab Biosimilar) antibody (PE) (ABIN7867305)

Target: HGF (Ficlatuzumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Monoclonal

Conjugate: This HGF (Ficlatuzumab Biosimilar) antibody is conjugated to PE

Application: Please inquire

Product Details anti-HGF (Ficlatuzumab Biosimilar) Antibody (PE)

Purpose: PE-conjugated Anti-HGF(ficlatuzumab biosimilar) mAb

Isotype: IgG1

Application Details

Application Notes: 1 μL/test

Restrictions: For Research Use only

Handling

Format: Liquid

Buffer: Liquid,PBS with,0.18 % BSA-0.1 %Proclin300

Preservative: ProClin

Precaution of Use: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: 4 °C

Storage Comment:  Store at 2°C-8°C for 6 months

Expiry Date: 6 months

Target Details for HGF (Ficlatuzumab Biosimilar)

Target: HGF (Ficlatuzumab Biosimilar)

Alternative Name: ficlatuzumab biosimilar

Target Type: Biosimilar

Background:

Synonyms: Hepatopoietin-A, SF, HPTA,AV-299, SCH 900105

Target Background: Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

UniProt: P14210